Annual Current Liabilities
$9.49 M
-$14.89 M-61.08%
31 December 2023
Summary:
Mereo BioPharma annual total current liabilities is currently $9.49 million, with the most recent change of -$14.89 million (-61.08%) on 31 December 2023. During the last 3 years, it has fallen by -$2.19 million (-18.73%). MREO annual current liabilities is now -75.79% below its all-time high of $39.17 million, reached on 31 December 2019.MREO Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$14.21 M
-$1.26 M-8.13%
30 September 2024
Summary:
Mereo BioPharma quarterly total current liabilities is currently $14.21 million, with the most recent change of -$1.26 million (-8.13%) on 30 September 2024. MREO quarterly current liabilities is now -66.73% below its all-time high of $42.70 million, reached on 30 June 2022.MREO Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MREO Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -61.1% | - |
| 3 y3 years | -18.7% | +4.0% |
| 5 y5 years | -53.8% | -46.8% |
MREO Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -61.1% | at low | -66.7% | +49.8% |
| 5 y | 5 years | -75.8% | at low | -66.7% | +49.8% |
| alltime | all time | -75.8% | +139.6% | -66.7% | +258.8% |
Mereo BioPharma Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $14.21 M(-8.1%) |
| June 2024 | - | $15.47 M(+40.5%) |
| Mar 2024 | - | $11.00 M(+16.0%) |
| Dec 2023 | $9.49 M(-61.1%) | $9.49 M(-56.9%) |
| June 2023 | - | $22.02 M(-9.7%) |
| Dec 2022 | $24.38 M(+44.0%) | $24.38 M(-42.9%) |
| June 2022 | - | $42.70 M(+152.3%) |
| Dec 2021 | $16.93 M(+45.0%) | $16.93 M(+23.9%) |
| June 2021 | - | $13.66 M(+17.1%) |
| Dec 2020 | $11.67 M | $11.67 M(-57.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2020 | - | $27.53 M(-29.7%) |
| Dec 2019 | $39.17 M(+90.8%) | $39.17 M(+46.8%) |
| June 2019 | - | $26.69 M(+30.0%) |
| Dec 2018 | $20.53 M(+57.9%) | $20.53 M(+11.0%) |
| June 2018 | - | $18.49 M(+42.3%) |
| Dec 2017 | $13.00 M(+228.3%) | $13.00 M(-16.3%) |
| June 2017 | - | $15.52 M(+292.0%) |
| Dec 2016 | $3.96 M(-32.8%) | $3.96 M(-49.0%) |
| June 2016 | - | $7.76 M(+31.7%) |
| Dec 2015 | $5.89 M | $5.89 M |
FAQ
- What is Mereo BioPharma annual total current liabilities?
- What is the all time high annual current liabilities for Mereo BioPharma?
- What is Mereo BioPharma annual current liabilities year-on-year change?
- What is Mereo BioPharma quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Mereo BioPharma?
What is Mereo BioPharma annual total current liabilities?
The current annual current liabilities of MREO is $9.49 M
What is the all time high annual current liabilities for Mereo BioPharma?
Mereo BioPharma all-time high annual total current liabilities is $39.17 M
What is Mereo BioPharma annual current liabilities year-on-year change?
Over the past year, MREO annual total current liabilities has changed by -$14.89 M (-61.08%)
What is Mereo BioPharma quarterly total current liabilities?
The current quarterly current liabilities of MREO is $14.21 M
What is the all time high quarterly current liabilities for Mereo BioPharma?
Mereo BioPharma all-time high quarterly total current liabilities is $42.70 M